| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Relationships > Relationships > Step 7 To An Ideal Realtionship: Always Look After Your Health |
|
Advice Pool - Step 7 To An Ideal Realtionship: Always Look After Your Health
In "Ten Steps To An Ideal Relationship" I note that Step 7 is about: always looking after your health According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product and well being. Without a solid foundation of good health any relationship will flounder. Your heal ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in th is your responsibility and not anyone else’s. This may seem like an obvious thing to do yet how o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ften do you see individuals neglecting their health. Well just look around and I think you can find s here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ome examples. What's even more interesting is that most of these people never consider the burden th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t that is going to have on their partner or their family. So now is that selfish or not? Why do indi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc viduals find themselves behaving in such self sabotaging ways? Well we could go on for hours about th easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi is one but if I address it in within the context of the relationship we have such reasons as: 1. Som nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e are unconsciously sabotaging their health so that they can get symapthy which they interpret as "lo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ve" from their partners. 2. Some are afraid of taking full responsibility for their part in the rela ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ionship and hence sink into an illness where they think they can hide. 3. Some use illness and ill h ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ealth as a way to assert control over and/or manipulate their partner and in the choices that are mad dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e between them. 4. Some are unconsciously recreating a child-parent relationship in which they hope cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to be taken care of by their partner. 5. Some believe that it is not their responsibility and theref tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ore never assume it. An so on. Well the conequences to a relationship can be devastating. Unfortuna t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ely if the partner is lacking in maturity they may not see how they are being used and may unwisely f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eel trapped by the guilt feelings that ensue when they think about confronting the "ill partner". Th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products is then only leads to a dynamic in which both sink into a morass of negativity with each other and wi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de thin themsleves. In other words the illness spreads and ultimately kills them both. If this is soun elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ding familiar is this what you want? If not then kindly visit the web link below to get some support tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Self-Leadership in the Public Sector: An Expert Analysis Want A Debt Free Life? Go for Secured Debt Consolidation Loans
|